In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.
GRCE READ THE FULL GRCE RESEARCH REPORT We are initiating coverage of Grace Therapeutics, Inc. (NASDAQ:GRCE) with a valuation of $12.50 per share. This value is based on our estimates for the successf ...
Chili (Capsicum annum L.) is a member of the Solanaceae family and is considered a vital vegetable cum spice, which is one of the most extensively cultivated crops worldwide. Morphologically, this is ...
PK: In response, our scientists figured out a way to solubilize the hydrophobic molecule nimodipine and create an aqueous formulation of nimodipine. This aqueous formulation now allows for an ...